CHELSEA RODENHOUSE: Open Payments
NPI 1518537067 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,031 in 73 payments from 11 companies in 2025. Trend: 2023 $756 · 2024 $1,433 · 2025 $2,031
Food & beverage: $1,280Travel & lodging: $692Education: $58
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 8 | $1,172 |
| ABBVIE INC. | 54 | $556 |
| Genentech USA, Inc. | 3 | $70 |
| Teva Pharmaceuticals USA, Inc. | 1 | $58 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| ARGENX US, INC. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $25 |
| Impel Pharmaceuticals LLC | 1 | $21 |
Products named: VNS Therapy, QULIPTA, UBRELVY, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, BOTOX, Ocrevus Zunovo, KESIMPTA, VYVGART HYTRULO.
Industry payments across NY — which companies pay providers there.
